StonvexLoading…
StonvexStonvexStonvexCore line items from BNKK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.12M | $701.97K | $202.67K | $120.63K |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $-68.19M | $-49.41M | $-15.08M | $-15.22M |
EPS (Diluted) | $-17.02 | $-31.77 | $-0.49 | $-0.69 |
Total Assets | $40.97M | $7.34M | $12.71M | $8.69M |
Total Liabilities | $5.98M | $9.51M | $3.89M | $5.03M |
Cash & Equivalents | $2.28M | $348.82K | $3.83M | $1.48M |
Free Cash Flow OCF − CapEx | Not available | $-18.18M | $-10.82M | $-6.41M |
Shares Outstanding | 7.75M | 1.79M | 45.63M | 22.34M |